Main menu

Addressing the global diagnostics gap for childhood leukaemias: a global, multisite type 2 hybrid validation study of nanopore-based Adaptive Sampling whole-genome sequencing

Addressing the global diagnostics gap for childhood leukaemias: a global, multisite type 2 hybrid validation study of nanopore-based Adaptive Sampling whole-genome sequencing
resources.return_to_resourcesresources.read_full_text
  • shared.published_on: May 21 2026
  • shared.source: medRxiv
resources.authors: Thomas B Alexander, Rubina Islam, Javeria Aijaz, Tristan Achterberg, Nancy Bolous, Karlijn Cammel, Jeroen de Ridder, Julie Geyer, Shannon Gray, Nicole Groenewegen, Shakir Hussain, Sadia Imran, Saba Jamal, Srijita Kar, Dona Kanavy, Neelum Mansoor, Mayur Parihar, Vaskar Saha, Bastiaan Tops, Marc van Tuil, David Wilkins, Karen Weck, Gang Wu, Liang Zhou, Lennart Kester, Jeremy R Wang, Nickhill Bhakta

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

© 2008 - 2023 Oxford Nanopore Technologies plc. All rights reserved. 登記された事務所：Gosling Building,\n Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK {'|'} 登記番号：05386273 {'|'} VAT番号：336942382。Oxford\n Nanopore Technologies、Wheel icon、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、\n PromethION、SmidgION、UbikおよびVolTRAXは様々な国で登録されたOxford Nanopore Technologies\nの商標です。Oxford Nanopore Technologies製品は、\n現在すべて研究用です。

Japanese flag